Average Co-Inventor Count = 7.72
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Palo Alto LLC (7 from 322 patents)
2. Amgen Inc. (3 from 1,974 patents)
3. University of California (2 from 15,475 patents)
4. Nurix Therapeutics, Inc. (2 from 14 patents)
5. F. Hoffmann-la Roche Ag (168 patents)
14 patents:
1. 11866442 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
2. 11479556 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
3. 10836720 - Inhibitors of integrin alpha 5 beta 1 and methods of use
4. 10214522 - Anti-alphavbeta1 integrin inhibitors and methods of use
5. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
6. 9376425 - Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
7. 9296736 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
8. 8822457 - Inhibitors of bruton's tyrosine kinase
9. 8618098 - Inhibitors of bruton's tyrosine kinase
10. 8124604 - Inhibitors of bruton's tyrosine kinase
11. 7906509 - Inhibitors of bruton's tyrosine kinase
12. 7902194 - Inhibitors of bruton's tyrosine kinase
13. 7683064 - Inhibitors of Bruton's tyrosine kinase
14. 7645764 - Kinase inhibitors and methods for using the same